Finch Therapeutics Group, Inc. (FNCHQ): Nasdaq/NYSE listing notice — Finch Therapeutics audit committee falls to 2 members; Nasdaq grants cure period until Mar 2025

Finch Therapeutics Group, Inc.

Susan Graf resigned from board on March 26, 2024, reducing audit committee to 2 independent directors.
Nasdaq requires audit committee of 3 independent directors; company notified Nasdaq on March 28.
Nasdaq notice received April 2; company has until March 26, 2025 or next annual meeting to regain compliance.
If next annual meeting is before September 23, 2024, cure deadline is September 23, 2024.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Finch Therapeutics Group, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2), 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(c)(2), 5605(c)(4)

Exact text from the filing

April 2, 2024, the Company received a notice from Nasdaq acknowledging the fact that the Company does not meet the requirements of such rules. In accordance with Nasdaq Listing Rule 5605(c)(4) and the Nasdaq notice, to regain compliance with the Nasdaq Listing Rules, the Company has until the earlier of March 26, 2025 or its next annual stockholders meeting (or, if the next annual stockholders meeting is held before September 23, 2024, until September 23, 2024) to regain compliance with the Nasdaq Listing Rules related to audit committee composition. SIGNATURES Pursuant to the requirements of

View on SEC.gov

Browse all listing & compliance notices →

Finch Therapeutics Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-085435

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.